Author: Farooq, Hamzah Z.; Cirillo, Daniela M.; Hillemann, Doris; Wyllie, David; van der Werf, Marieke J.; Ködmön, Csaba; Nikolayevskyy, Vlad
Title: Limited Capability for Testing Mycobacterium tuberculosis for Susceptibility to New Drugs Cord-id: lfsmj079 Document date: 2021_3_25
ID: lfsmj079
Snippet: We surveyed availability of phenotypic drug susceptibility testing for drug-resistant Mycobacterium tuberculosis in Europe. Of 27 laboratories, 17 tested for linezolid, 11 for clofazimine, 9 for bedaquiline, and 6 for delamanid during 2019. Our findings indicate that testing capacity for newer and repurposed tuberculosis drugs exists, but its availability is limited.
Document: We surveyed availability of phenotypic drug susceptibility testing for drug-resistant Mycobacterium tuberculosis in Europe. Of 27 laboratories, 17 tested for linezolid, 11 for clofazimine, 9 for bedaquiline, and 6 for delamanid during 2019. Our findings indicate that testing capacity for newer and repurposed tuberculosis drugs exists, but its availability is limited.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date